Rainmed Medical Limited has issued a proxy form outlining the key items to be tabled at the annual general meeting scheduled for 10:30 a.m. on Monday, 29 June 2026, at Room NW-05-502, Northwest District, Nanopolis Suzhou, Jiangsu Province.
Key resolutions:
1. 2025 Financial Statements • Shareholders will consider and adopt the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.
2. Board Composition • Re-election of three executive directors—Mr. Huo Yunfei, Mr. Zhu Zeke and Ms. Duan Jing—and two independent non-executive directors—Mr. Chen Xuefeng and Mr. Zhao Hui. • Authorisation for the board to determine directors’ remuneration.
3. Auditor • Renewal of SHINEWING (HK) CPA Limited as external auditor until the conclusion of the 2027 AGM, with the board authorised to fix its fees for the 2026 financial year.
4. Share Capital Mandates • General mandate permitting the board to allot, issue and deal with additional shares. • Authorisation to repurchase the company’s own shares. • Extension of the issue mandate by an amount equivalent to shares repurchased under the buy-back mandate.
Administrative details:
• Shareholders of HK$0.0001 par-value shares may appoint proxies; completed forms must reach Tricor Investor Services Limited at least 48 hours before the meeting. • Each share carries one vote on a poll. Joint holders may vote, with priority given to the first-named holder on the register.
The proposed resolutions aim to renew core corporate governance arrangements and provide the board with flexibility over capital management ahead of the company’s next financial cycle.
Comments